Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / POSTN

POSTN

Basics

Aliases:
This biomarker is also known as:
  • OSF-2,
  • periostin, osteoblast specific factor,
  • periostin,
  • Osteoblast-specific factor 2,
  • OSF2,
  • PN,

View in BioMuta

Description…

POSTN, a secreted protein, binds to heparin and induces cell attachment and spreading. It may additionally play a role in cell adhesion and in extracellular matrix mineralization. POSTN is widely expressed with highest levels in aorta, stomach, lower gastrointestinal tract, placenta, uterus and breast. It is up-regulated in epithelial ovarian tumors while not expressed in normal ovaries. POSTN is also highly expressed at the tumor periphery of lung carcinoma tissue but not within the tumor. It is overexpressed in breast cancers.

Attributes

QA State: Under Review
Type: Protein
Short Name:

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Announcement 09/14/2014

Thank you to everyone who helped make the 9th EDRN Scientific Workshop a success. We look forward to seeing everyone at the 28th EDRN Steering Committee Meeting from March 31-April 2, 2015, in Atlanta, GA.

Announcement 06/05/2014


Funding Opportunity Available

Both RFAs for Molecular and Cellular Characterization of Screen-Detected Lesions have been published.

RFA-CA-14-010.html

and

RFA-CA-14-011.html